Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 2/2012

01.03.2012 | Original Article

Physical training increases osteoprotegerin in postmenopausal women

verfasst von: Ingrid Bergström, Paolo Parini, Sven A. Gustafsson, Göran Andersson, Jonas Brinck

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to explore whether mechanical loading by exercise over a 1–year period in postmenopausal women had an effect on the receptor activator for nuclear factor kappa B ligand/osteoprotegerin (RANKL/OPG) system or the levels of the Wnt-signaling antagonist sclerostin. A total of 112 postmenopausal were randomized to either sedentary life (controls) or physical activity (training group). Ninety-two women fulfilled the study protocol. The training program consisted of three fast 30-min walks and one or two 1-h aerobic training sessions per week. The effect on the bone mineral density of the hip assessed with dual X-ray absorptiometry was positive as reported earlier. Blood samples were taken from participants at baseline and after 1 year and serum levels of OPG, RANKL and sclerostin were quantified together with the bone metabolism markers C-terminal telopeptide of collagen type I (CTX) and bone-specific alkaline phosphatase (BALP). The results were analyzed using an analysis of covariance model using baseline values as the covariate. The training group displayed a clear mean increase of OPG +7.55 pg/ml compared to controls (p = 0.007). The mean changes for RANKL +0.19 pg/ml (square-root transformed data) and sclerostin +0.62 pmol/l were non-significant (p = 0.13 and p = 0.34). The changes in bone turnover markers CTX and BALP showed a tendency to decrease in the training group versus controls but the changes were small and non-significant. Although our study is limited in number of participating women, we have been able to show an OPG-associated, and RANKL- and sclerostin-independent, training-induced inhibition of postmenopausal bone loss.
Literatur
1.
Zurück zum Zitat Prince RL, Draper C (2000) Bone and calcium. In: Lobo RA, Kelsey J, Marcus R (eds) Menopause. Academic Press, USA, pp 287–294CrossRef Prince RL, Draper C (2000) Bone and calcium. In: Lobo RA, Kelsey J, Marcus R (eds) Menopause. Academic Press, USA, pp 287–294CrossRef
2.
Zurück zum Zitat Lian JB, Stein GS (2001) Osteoblast biology. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 33–35 Lian JB, Stein GS (2001) Osteoblast biology. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 33–35
3.
Zurück zum Zitat Kim CH, You L, Yellowley CE, Jacobs CR (2006) Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling. Bone 39:1043–1047PubMedCrossRef Kim CH, You L, Yellowley CE, Jacobs CR (2006) Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling. Bone 39:1043–1047PubMedCrossRef
4.
Zurück zum Zitat You L, Temiyasathit S, Lee P, Kim CH, Tummala P, Yao W, Kingery W, Malone AM, Kwon RY, Jacobs CR (2008) Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone 42:172–179PubMedCrossRef You L, Temiyasathit S, Lee P, Kim CH, Tummala P, Yao W, Kingery W, Malone AM, Kwon RY, Jacobs CR (2008) Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone 42:172–179PubMedCrossRef
5.
Zurück zum Zitat Vega D, Maalouf NM, Sakhaee K (2007) CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 92:4514–4521PubMedCrossRef Vega D, Maalouf NM, Sakhaee K (2007) CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 92:4514–4521PubMedCrossRef
7.
Zurück zum Zitat Avbersek-Luznik I, Gmeiner Stopar T, Marc J (2007) Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation. Clin Chem Lab Med 45:1014–1018PubMedCrossRef Avbersek-Luznik I, Gmeiner Stopar T, Marc J (2007) Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation. Clin Chem Lab Med 45:1014–1018PubMedCrossRef
8.
Zurück zum Zitat Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRef Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRef
9.
Zurück zum Zitat Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM (2004) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 19:1059–1066PubMedCrossRef Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM (2004) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 19:1059–1066PubMedCrossRef
10.
Zurück zum Zitat Samelson EJ, Broe KE, Demissie S, Beck TJ, Karasik D, Kathiresan S, Kiel DP (2008) Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip. J Clin Endocrinol Metab 93:1789–1795PubMedCrossRef Samelson EJ, Broe KE, Demissie S, Beck TJ, Karasik D, Kathiresan S, Kiel DP (2008) Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip. J Clin Endocrinol Metab 93:1789–1795PubMedCrossRef
11.
Zurück zum Zitat Saunders MM, Taylor AF, Du C, Zhou Z, Pellegrini VD Jr, Donahue HJ (2006) Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells. J Biomech 39:1419–1427PubMedCrossRef Saunders MM, Taylor AF, Du C, Zhou Z, Pellegrini VD Jr, Donahue HJ (2006) Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells. J Biomech 39:1419–1427PubMedCrossRef
12.
Zurück zum Zitat Mehrotra M, Saegusa M, Wadhwa S, Voznesensky O, Peterson D, Pilbeam C (2006) Fluid flow induces Rankl expression in primary murine calvarial osteoblasts. J Cell Biochem 98:1271–1283PubMedCrossRef Mehrotra M, Saegusa M, Wadhwa S, Voznesensky O, Peterson D, Pilbeam C (2006) Fluid flow induces Rankl expression in primary murine calvarial osteoblasts. J Cell Biochem 98:1271–1283PubMedCrossRef
13.
Zurück zum Zitat Tang L, Lin Z, Li YM (2006) Effects of different magnitudes of mechanical strain on Osteoblasts in vitro. Biochem Biophys Res Commun 344:122–128PubMedCrossRef Tang L, Lin Z, Li YM (2006) Effects of different magnitudes of mechanical strain on Osteoblasts in vitro. Biochem Biophys Res Commun 344:122–128PubMedCrossRef
14.
Zurück zum Zitat Kusumi A, Sakaki H, Kusumi T, Oda M, Narita K, Nakagawa H, Kubota K, Satoh H, Kimura H (2005) Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain. J Bone Miner Metab 23:373–381PubMedCrossRef Kusumi A, Sakaki H, Kusumi T, Oda M, Narita K, Nakagawa H, Kubota K, Satoh H, Kimura H (2005) Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain. J Bone Miner Metab 23:373–381PubMedCrossRef
15.
Zurück zum Zitat West SL, Scheid JL, De Souza MJ (2009) The effect of exercise and estrogen on osteoprotegerin in premenopausal women. Bone 44:137–144PubMedCrossRef West SL, Scheid JL, De Souza MJ (2009) The effect of exercise and estrogen on osteoprotegerin in premenopausal women. Bone 44:137–144PubMedCrossRef
16.
Zurück zum Zitat Ziegler S, Niessner A, Richter B, Wirth S, Billensteiner E, Woloszczuk W, Slany J, Geyer G (2005) Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor kappa B ligand. Metabolism 54:935–938PubMedCrossRef Ziegler S, Niessner A, Richter B, Wirth S, Billensteiner E, Woloszczuk W, Slany J, Geyer G (2005) Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor kappa B ligand. Metabolism 54:935–938PubMedCrossRef
18.
Zurück zum Zitat Piters E, Boudin E, Van Hul W (2008) Wnt signaling: a win for bone. Arch Biochem Biophys 473:112–116PubMedCrossRef Piters E, Boudin E, Van Hul W (2008) Wnt signaling: a win for bone. Arch Biochem Biophys 473:112–116PubMedCrossRef
19.
Zurück zum Zitat Moustafa A, Sugiyama T, Saxon LK, Zaman G, Sunters A, Armstrong VJ, Javaheri B, Lanyon LE, Price JS (2009) The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading. Bone 44:930–935PubMedCrossRef Moustafa A, Sugiyama T, Saxon LK, Zaman G, Sunters A, Armstrong VJ, Javaheri B, Lanyon LE, Price JS (2009) The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading. Bone 44:930–935PubMedCrossRef
20.
Zurück zum Zitat Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283:5866–5875PubMedCrossRef Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283:5866–5875PubMedCrossRef
21.
Zurück zum Zitat Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95; 2248−2253 Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico RA, Pulvirenti I, Hawa G, Tringali G, Fiore CE. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95; 2248−2253
22.
Zurück zum Zitat Bergstrom I, Landgren B, Brinck J, Freyschuss B (2008) Physical training preserves bone mineral density in postmenopausal women with forearm fractures and low bone mineral density. Osteoporos Int 19:177–183PubMedCrossRef Bergstrom I, Landgren B, Brinck J, Freyschuss B (2008) Physical training preserves bone mineral density in postmenopausal women with forearm fractures and low bone mineral density. Osteoporos Int 19:177–183PubMedCrossRef
23.
Zurück zum Zitat Bergstrom I, Lombardo C, Brinck J (2009) Physical training decreases waist circumference in postmenopausal borderline overweight women. Acta Obstet Gynecol Scand 88:308–313PubMedCrossRef Bergstrom I, Lombardo C, Brinck J (2009) Physical training decreases waist circumference in postmenopausal borderline overweight women. Acta Obstet Gynecol Scand 88:308–313PubMedCrossRef
24.
Zurück zum Zitat Price JS, Sugiyama T, Galea GL, Meakin LB, Sunters A, Lanyon LE. Role of endocrine and paracrine factors in the adaptation of bone to mechanical loading. Curr Osteoporos Rep 9; 76−82 Price JS, Sugiyama T, Galea GL, Meakin LB, Sunters A, Lanyon LE. Role of endocrine and paracrine factors in the adaptation of bone to mechanical loading. Curr Osteoporos Rep 9; 76−82
25.
Zurück zum Zitat Bergstrom I, Freyschuss B, Landgren BM (2005) Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study. Osteoporos Int 16:823–828PubMedCrossRef Bergstrom I, Freyschuss B, Landgren BM (2005) Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study. Osteoporos Int 16:823–828PubMedCrossRef
Metadaten
Titel
Physical training increases osteoprotegerin in postmenopausal women
verfasst von
Ingrid Bergström
Paolo Parini
Sven A. Gustafsson
Göran Andersson
Jonas Brinck
Publikationsdatum
01.03.2012
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 2/2012
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-011-0304-6

Weitere Artikel der Ausgabe 2/2012

Journal of Bone and Mineral Metabolism 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.